Subscribe
shutterstock_384310168_doro_guzenda
Doro Guzenda / Shutterstock.com
19 April 2022MedtechFran Salisbury and Alice Jefferies

Predicting the unpredictable during pregnancy

A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

More features

White & Case hires experienced litigator from A&O Shearman
China’s new policies on foreign investment in healthcare and biotech
Startup CFO’s betrayal is a lesson in preparing for the worst
Apple wins just $250 in Masimo smartwatch clash
How post-filing data rescued Novo Nordisk’s Ozempic patent in China
How to navigate patent term adjustment in China
‘I’m breaking new ground’: Mölnlycke’s first TM attorney charts a new course
Preventative IP for preventative pharma healthcare